Green Planet Bio Engineering Company. Ltd
Green Planet Bioengineering Co., Ltd. does not have significant operations. It was previously engaged in the manufacture, marketing, and sale of extracts from tobacco leaves residues in the People's Republic of China. The company was formerly known as Mondo Acquisition II, Inc. and changed its name to Green Planet Bioengineering Co., Ltd. on October 02, 2008. Green Planet Bioengineering Co., Ltd.… Read more
Green Planet Bio Engineering Company. Ltd (GPLB) - Net Assets
Latest net assets as of September 2025: $-484.68K USD
Based on the latest financial reports, Green Planet Bio Engineering Company. Ltd (GPLB) has net assets worth $-484.68K USD as of September 2025.
Net assets (also known as shareholders' equity or book value) represent the difference between a company's total assets ($0.00) and total liabilities ($484.68K). This figure indicates the residual interest in the assets after deducting liabilities, essentially showing what would remain for shareholders if all assets were liquidated and all debts paid off.
Key Net Assets Metrics
| Metric | Value |
|---|---|
| Current Net Assets | $-484.68K |
| % of Total Assets | 0% |
| Annual Growth Rate | N/A |
| 5-Year Change | N/A |
| 10-Year Change | N/A |
| Growth Volatility | 76.16 |
Green Planet Bio Engineering Company. Ltd - Net Assets Trend (2007–2024)
This chart illustrates how Green Planet Bio Engineering Company. Ltd's net assets have evolved over time, based on quarterly financial data. Explore and compare other companies by net assets.
Annual Net Assets for Green Planet Bio Engineering Company. Ltd (2007–2024)
The table below shows the annual net assets of Green Planet Bio Engineering Company. Ltd from 2007 to 2024.
| Year | Net Assets | Change |
|---|---|---|
| 2024-12-31 | $-465.13K | -8.27% |
| 2023-12-31 | $-429.59K | -12.48% |
| 2022-12-31 | $-381.92K | -9.31% |
| 2021-12-31 | $-349.39K | -10.41% |
| 2020-12-31 | $-316.46K | +2.06% |
| 2019-12-31 | $-323.10K | -25.47% |
| 2018-12-31 | $-257.50K | -18.52% |
| 2017-12-31 | $-217.26K | -18.45% |
| 2016-12-31 | $-183.41K | -3.09% |
| 2011-12-31 | $-177.92K | -14.56% |
| 2010-12-31 | $-155.31K | -100.65% |
| 2009-12-31 | $23.82 Million | +66.15% |
| 2008-12-31 | $14.34 Million | +55.12% |
| 2007-12-31 | $9.24 Million | -- |
Equity Component Analysis
This analysis shows how different components contribute to Green Planet Bio Engineering Company. Ltd's total equity over time. Equity components include common stock, retained earnings, additional paid-in capital, and other elements.
Equity Composition Insights
- Retained earnings have decreased by 128.1% over the analyzed period, potentially due to dividend distributions or operating losses.
Current Equity Component Breakdown (December 2024)
| Component | Amount | Percentage |
|---|---|---|
| Common Stock | $20.01K | % |
| Other Components | $609.61K | % |
| Total Equity | $-465.13K | 100.00% |
Green Planet Bio Engineering Company. Ltd Competitors by Market Cap
The table below lists competitors of Green Planet Bio Engineering Company. Ltd ranked by their market capitalization.
| Company | Market Cap |
|---|---|
|
Thrive Tribe Technologies Ltd
AU:1TT
|
$300.18K |
|
Cardinal Infrastructure Group Inc. Class A Common Stock
NASDAQ:CDNL
|
$300.20K |
|
ISUN INC. DL-0001
F:4U1A
|
$300.33K |
|
ELEKTROBIT
BE:JOT
|
$300.40K |
|
Nextcom
TA:NXTM
|
$299.92K |
|
PROGRESS-WERK
BE:PWO
|
$299.58K |
|
Ireka Corporation Bhd
KLSE:8834
|
$299.54K |
|
PKNORLEN
MU:PKY1
|
$299.51K |
Equity Growth Attribution
This analysis shows how different factors contributed to changes in Green Planet Bio Engineering Company. Ltd's equity between the two most recent reporting periods.
Equity Growth Insights
- From 2023 to 2024, total equity changed from -429,590 to -465,134, a change of -35,544.
- Net loss of 35,544 reduced equity.
- Other factors decreased equity by 0.
Equity Change Factors (2023 to 2024)
| Factor | Impact | Contribution |
|---|---|---|
| Net Income | $-35.54K | -7.64% |
| Total Change | $- | % |
Book Value vs Market Value Analysis
This analysis compares Green Planet Bio Engineering Company. Ltd's book value (net assets) with its market value over time. The relationship between these values can provide insights into investor sentiment and company valuation.
Valuation Insights
Historical Price-to-Book Ratios
| Date | Book Value per Share | Market Price | P/B Ratio |
|---|---|---|---|
| 2007-12-31 | $9.24 | $0.51 | x |
| 2008-12-31 | $0.94 | $0.51 | x |
| 2009-12-31 | $1.38 | $0.51 | x |
| 2010-12-31 | $-0.01 | $0.51 | x |
| 2011-12-31 | $-0.01 | $0.51 | x |
| 2012-12-31 | $0.00 | $0.51 | x |
| 2013-12-31 | $0.00 | $0.51 | x |
| 2014-12-31 | $-0.01 | $0.51 | x |
| 2015-12-31 | $-0.01 | $0.51 | x |
| 2016-12-31 | $-0.01 | $0.51 | x |
| 2017-12-31 | $-0.01 | $0.51 | x |
| 2018-12-31 | $-0.01 | $0.51 | x |
| 2019-12-31 | $-0.01 | $0.51 | x |
| 2020-12-31 | $-0.02 | $0.51 | x |
| 2021-12-31 | $-0.02 | $0.51 | x |
| 2022-12-31 | $-0.02 | $0.51 | x |
| 2023-12-31 | $-0.02 | $0.51 | x |
| 2024-12-31 | $-0.02 | $0.51 | x |
Capital Efficiency Dashboard
This dashboard shows how efficiently Green Planet Bio Engineering Company. Ltd utilizes its equity to generate returns, including Return on Equity (ROE) and its components based on the DuPont analysis framework.
Capital Efficiency Insights
- Current Return on Equity (ROE): 0.00%
- The company may be facing challenges in efficiently utilizing shareholder equity.
- DuPont Analysis Breakdown:
- • Net Profit Margin: 0.00%
- • Asset Turnover: 0.00x
- • Equity Multiplier: 0.00x
- Recent ROE (0.00%) is below the historical average (3.92%), suggesting potential challenges in capital efficiency.
Historical Capital Efficiency Metrics
| Year | Return on Equity | Net Profit Margin | Asset Turnover | Equity Multiplier | Economic Value Added |
|---|---|---|---|---|---|
| 2007 | 29.10% | 33.37% | 0.59x | 1.49x | $1.77 Million |
| 2008 | 23.37% | 32.21% | 0.62x | 1.17x | $1.92 Million |
| 2009 | 18.13% | 32.47% | 0.47x | 1.18x | $1.94 Million |
| 2010 | 0.00% | 0.00% | 0.00x | 0.00x | $818.09K |
| 2011 | 0.00% | 0.00% | 0.00x | 0.00x | $-4.82K |
| 2012 | 0.00% | 0.00% | 0.00x | 0.00x | $-39.21K |
| 2013 | 0.00% | 0.00% | 0.00x | 0.00x | $-26.69K |
| 2014 | 0.00% | 0.00% | 0.00x | 0.00x | $-26.04K |
| 2015 | 0.00% | 0.00% | 0.00x | 0.00x | $-18.24K |
| 2016 | 0.00% | 0.00% | 0.00x | 0.00x | $-17.31K |
| 2017 | 0.00% | 0.00% | 0.00x | 0.00x | $-12.12K |
| 2018 | 0.00% | 0.00% | 0.00x | 0.00x | $-14.49K |
| 2019 | 0.00% | 0.00% | 0.00x | 0.00x | $2.93K |
| 2020 | 0.00% | 0.00% | 0.00x | 0.00x | $-1.95K |
| 2021 | 0.00% | 0.00% | 0.00x | 0.00x | $2.01K |
| 2022 | 0.00% | 0.00% | 0.00x | 0.00x | $5.66K |
| 2023 | 0.00% | 0.00% | 0.00x | 0.00x | $-4.71K |
| 2024 | 0.00% | 0.00% | 0.00x | 0.00x | $10.97K |
Industry Comparison
This section compares Green Planet Bio Engineering Company. Ltd's net assets metrics with peer companies in the Shell Companies industry.
Industry Context
- Industry: Shell Companies
- Average net assets among peers: $36,677,338
- Average return on equity (ROE) among peers: -64.57%
Peer Company Comparison
| Company | Net Assets | Return on Equity | Debt-to-Equity | Market Cap |
|---|---|---|---|---|
| Green Planet Bio Engineering Company. Ltd (GPLB) | $-484.68K | 29.10% | N/A | $300.10K |
| Artius II Acquisition Inc. Class A Ordinary Shares (AACB) | $-60.27K | 0.00% | 0.00x | $198.37 Million |
| Artius II Acquisition Inc. Units (AACBU) | $-60.27K | 0.00% | 0.00x | $205.28 Million |
| Ares Acquisition Corporation II (AACT-UN) | $931.34 Million | 0.00% | 0.08x | $399.77 Million |
| AA Mission Acquisition Corp. (AAM-UN) | $-559.90 Million | 0.00% | 0.00x | $349.76 Million |
| Global Acquisitions Corporation (AASP) | $3.80 Million | -5.26% | 0.34x | $15.42 Million |
| ABV Consulting Inc (ABVN) | $8.75K | -623.31% | 2.50x | $461.96K |
| Atlantic Coastal Acquisition Corp II (ACAB) | $-8.52 Million | 0.00% | 0.00x | $2.44 Million |
| Annabidiol Corp (ACBD) | $-501.57K | 0.00% | 0.00x | $13.62K |
| ACRO Biomedical Co Ltd (ACBM) | $685.87K | -17.12% | 0.46x | $30.04K |
| Huaizhong Health Group Inc (ADAD) | $-19.47K | 0.00% | 0.00x | $3.15K |